Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ustekinumab, ATC L04AC05

AOK Bayern - Die GesundheitskasseMünchen, GermanyNot disclosed715 days leftopen

Registrieren zum Speichern Documents (1)

Opportunity Score

Confidence: 60%

Complexity: low

715 days

Deadline

supplies

Contract

Framework

Deep Portfolio Analysis

Company fit score
Missing certificates
Eligibility blockers
Bid / No-Bid recommendation

Create account for AI analysis

AI Analysis Summary

Moderate opportunity

This is an open-house model (not a public procurement) by AOK Bayern for non-exclusive rebate agreements on the active substance Ustekinumab (ATC L04AC05). Any eligible pharmaceutical company can join by submitting a signed declaration of reliability and the contract documents. No selection process; all eligible applicants are accepted. The contract runs from August 1, 2026, to July 31, 2028, with possible early termination and auto-supersession by other rebate contracts. Submission is possible until June 3, 2028, with monthly cut-off dates for contract start.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Only pharmaceutical companies are eligible as potential partners
Submission of a completed and signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
Submission of signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Identifier

DE811695320

Lots (1)

#LOT-0001Open house Arzneimittelrabattverträge Ustekinumab, ATC L04AC05

Single lot for non-exclusive rebate agreements on Ustekinumab (ATC L04AC05). All eligible pharmaceutical companies can conclude identical, non-negotiable contracts.

33600000DEU